Search | TVST | ARVO Journals

Showing 1 – 20 of 27

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Real-world outcomes of faricimab injections in treatment-naïve neovascular age-related macular degeneration (nAMD) patients: The Moorfields Experience

Sing Yue Sim; Luke Nicholson; Praveen J Patel; Bhairavi Bhatia; Evangelia Chalkiadaki; Georgios Koutsocheras; Senthil Selvam; Sobha Sivaprasad; Bishwanath Pal; Pearse Andrew Keane; Robin Hamilton

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):246.

ARVO Annual Meeting Abstract June 2024

Intraocular Inflammation Associated with Faricimab Therapy: The Moorfields Experience.

Andrea Montesel; Sagnik Sen; Ella Preston; Sing Yue Sim; Praveen J Patel; Josef Christian Huemer; Robin Hamilton; Luke Nicholson; William Tucker; Ioannis Papasavvas; Ian Yeung

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):245.

ARVO Annual Meeting Abstract June 2024

Comparative analysis of anatomical and visual parameters in treatment-resistant neovascular age related macular degeneration (nAMD) patients pre- and post-switch to faricimab: A Moorfields Analysis

Georgios Koutsocheras; Evangelia Chalkiadaki; Sing Yue Sim; Senthil Selvam; Bhairavi Bhatia; Sobha Sivaprasad; Bishwanath Pal; Pearse Andrew Keane; Luke Nicholson; Robin Hamilton; Praveen J Patel

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4316.

ARVO Annual Meeting Abstract June 2024

Outcomes from hydroxychloroquine retinopathy screening utilising OCT and autofluorescence as the primary imaging modality

Gilad Allon; Bahar Demir; Olayinka Williams; Luke Nicholson; Ling Zhi-Heng

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):813.

ARVO Annual Meeting Abstract June 2024

Real-world outcomes of a Ranibizumab biosimilar product (Ongavia) in neovascular age related macular degeneration (nAMD) patients switched from a reference Ranibizumab product (Lucentis)

Evangelia Chalkiadaki; Abu Karim; Ian Yeung; Georgios Koutsocheras; Sing Yue Sim; Bishwanath Pal; Sobha Sivaprasad; Luke Nicholson; Robin Hamilton

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1944.

ARVO Annual Meeting Abstract June 2024

Assessment of artificial intelligence to determine referral pathways in a real-world population of the English Diabetic Eye Screening Programme (DESP)

Tunde Peto; Giulia Bignami; Anne-Marie Cairns; Ashleigh Kernohan; Philip Kirby; Sobha Sivaprasad; Dominik Temmesfeld; Luke Vale; Sunny Virmani; Lin Yang; Xiang Yin; Xiang Ji; Luke Nicholson

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4921.

ARVO Annual Meeting Abstract June 2024

Impact of Disease Activity Criteria on Extending Injection Intervals in Real-World Patients with Neovascular Age-related Macular Degeneration: A Moorfields Analysis

Bhairavi Bhatia; Sing Yue Sim; Evangelia Chalkiadaki; Georgios Koutsocheras; Luke Nicholson; Senthil Sevlam; Pearse Andrew Keane; Bishwanath Pal; Sobha Sivaprasad; Robin Hamilton; Praveen J Patel

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4902.

ARVO Annual Meeting Abstract June 2023

Five-year outcomes of ranibizumab for myopic choroidal neovascular membrane stratified by age of onset

Priyanka Sanghi; Filipa Rodrigues; Binu John; Karina Spiess; Judytna Jankowska-Szmul; Dhakshi Muhundhakumar; Theodora Gkika; Rola Baabbad; Simona Degli Esposti; Robin Hamilton; Sobha Sivaprasad; Bishwanath Pal; Luke Nicholson

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1557.

ARVO Annual Meeting Abstract June 2023

Anatomical and visual outcomes of patients with active neovascular age related macular degeneration(nAMD) requiring monthly anti-VEGF treatment following switch to faricimab

Sing Yue Sim; Evangelia Chalkiadaki; Georgios Koutsocheras; Robin Hamilton; Luke Nicholson; Bishwanath Pal; Praveen J Patel; Pearse Keane; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2206.

ARVO Annual Meeting Abstract June 2020

Phenotypic Characterization of Choroidal Neovascularization in Pachychoroid Spectrum Using Multi-modal Imaging

Hagar Khalid; Josef Christian Huemer; Shruti Chandra; Luke Nicholson; Siegfried Wagner; Daniel Ferraz; Farid Afshar; Katrin Fasler; Konstantinos Balaskas; Sobha Sivaprasad; Pearse Keane

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3235.

ARVO Annual Meeting Abstract June 2020

Choroidal neovascularization mimics in chronic central serous chorioretinopathy; an optical coherence tomography angiography study.

Laxmi Raja; Hagar Khalid; Josef Christian Huemer; Shruti Chandra; Luke Nicholson; Siegfried Wagner; Daniel Ferraz; Ahmed M Hagag; Dawn A Sim; Konstantinos Balaskas; Sobha Sivaprasad; Gongyu Zhang; Pearse Andrew Keane

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4811.

ARVO Annual Meeting Abstract July 2019

Real–life evidence for using a treat-and-extend injection regime for patients with central retinal vein occlusion.

Maria Eleftheriadou; Luke Nicholson; Giulia D'Alonzo; Peter Addison

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2584.

ARVO Annual Meeting Abstract July 2019

Ultra Wide-Field en face Swept-Source Optical Coherence Tomography Angiography Application in Proliferative Diabetic Retinopathy

Hagar Khalid; Luke Nicholson; Roy Schwartz; Mohamed El-Bradey; Dawn A Sim; Konstantinos Balaskas; Pearse Andrew Keane; Ranjan Rajendram

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3029.

ARVO Annual Meeting Abstract July 2019

Repeatability of central macular thickness in non-centre involving diabetic macular oedema – analysis of the CLEOPATRA trial

Thushanthi Ramakrishnan; Luke Nicholson; namritha patrao; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5330.

Retina May 2019

The Relationship Between Retinal Vessel Oxygenation and Spatial Distribution of Retinal Nonperfusion in Retinal Vascular Diseases

PDF

Luke Nicholson; Clara Vazquez-Alfageme; Philip G. Hykin; James W. Bainbridge; Sobha Sivaprasad
TAGS: alveolar ventilation function, cell respiration, oximetry, retinal vascular disorders, retinal vessels
Invest. Ophthalmol. Vis. Sci.. 2019; 60(6):2083-2087. https://doi.org/10.1167/iovs.18-24917

Retina August 2018

Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy

PDF

Luke Nicholson; Roxanne Crosby-Nwaobi; Joana C. Vasconcelos; A. Toby Prevost; Jayashree Ramu; Amy Riddell; James W. Bainbridge; Philip G. Hykin; Sobha Sivaprasad
TAGS: aflibercept, panretinal photocoagulation, proliferative diabetic retinopathy, eye, oximetry
Invest. Ophthalmol. Vis. Sci.. 2018; 59(10):4277-4284. https://doi.org/10.1167/iovs.17-23509

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

A Multicentre Double-masked Randomised Controlled Non-Inferiority Trial comparing clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eylea) vs bevacizumab (Avastin) for Macular Oedema due to Central Retinal Vein Occlusion [LEAVO]: Baseline patient sociodemographic and ocular characteristics.

Philip G Hykin; Joana Vasconcelas; Toby Prevost; Sobha Sivaprasad; Barry Hounsome; Usha Chakravarthy; Simon Harding; Andrew Lotery; Yit C. Yang; Piyali Sen; Jayashree Ramu; Luke Nicholson; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2569.

ARVO Annual Meeting Abstract June 2017

Retinal morphology and vessel oxygen saturation in normal and diabetic patients

Adam M Dubis; Luke Nicholson; Roxanne Crosby-Nwaobi; Phil Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3033.

ARVO Annual Meeting Abstract September 2016

Changes in Disorganization of Retinal Inner Layers (DRIL) Predict Retinal Sensitivity in Eyes with Diabetic Macular Edema

Timothy Peiris; Oliver Comyn; Luke Nicholson; Amanda Delacruz; Migil Ledesma; Philip Hykin; Sobha Sivaprasad; Paolo Sandico Silva; Lloyd Paul Aiello; Jennifer K Sun

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract September 2016

Real-world one year outcomes of a switch to aflibercept from ranibizumab in neovascular age related macular degeneration

Maria Cristina Citu; Roxanne R Crosby-Nwaobi; Maria Eleftheriadou; Clara Vazquez-Alfageme; Luke Nicholson; Sobha Sivaprasad; Philip Hykin; Robin D Hamilton

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3342.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Real-world outcomes of faricimab injections in treatment-naïve neovascular age-related macular degeneration (nAMD) patients: The Moorfields Experience

Intraocular Inflammation Associated with Faricimab Therapy: The Moorfields Experience.

Comparative analysis of anatomical and visual parameters in treatment-resistant neovascular age related macular degeneration (nAMD) patients pre- and post-switch to faricimab: A Moorfields Analysis

Outcomes from hydroxychloroquine retinopathy screening utilising OCT and autofluorescence as the primary imaging modality

Real-world outcomes of a Ranibizumab biosimilar product (Ongavia) in neovascular age related macular degeneration (nAMD) patients switched from a reference Ranibizumab product (Lucentis)

Assessment of artificial intelligence to determine referral pathways in a real-world population of the English Diabetic Eye Screening Programme (DESP)

Impact of Disease Activity Criteria on Extending Injection Intervals in Real-World Patients with Neovascular Age-related Macular Degeneration: A Moorfields Analysis

Five-year outcomes of ranibizumab for myopic choroidal neovascular membrane stratified by age of onset

Anatomical and visual outcomes of patients with active neovascular age related macular degeneration(nAMD) requiring monthly anti-VEGF treatment following switch to faricimab

Phenotypic Characterization of Choroidal Neovascularization in Pachychoroid Spectrum Using Multi-modal Imaging

Choroidal neovascularization mimics in chronic central serous chorioretinopathy; an optical coherence tomography angiography study.

Real–life evidence for using a treat-and-extend injection regime for patients with central retinal vein occlusion.

Ultra Wide-Field en face Swept-Source Optical Coherence Tomography Angiography Application in Proliferative Diabetic Retinopathy

Repeatability of central macular thickness in non-centre involving diabetic macular oedema – analysis of the CLEOPATRA trial

The Relationship Between Retinal Vessel Oxygenation and Spatial Distribution of Retinal Nonperfusion in Retinal Vascular Diseases

Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy

Retinal morphology and vessel oxygen saturation in normal and diabetic patients

Changes in Disorganization of Retinal Inner Layers (DRIL) Predict Retinal Sensitivity in Eyes with Diabetic Macular Edema

Real-world one year outcomes of a switch to aflibercept from ranibizumab in neovascular age related macular degeneration

To View More...

You must be signed into an individual account to use this feature.